Promising iron oxide-based magnetic nanoparticles in biomedical engineering

Archives of Pharmacal Research

Volumn 35, Issue 12, 2012, Pages 2045-2061

  Tran, Phuong Ha Lien ^a   Tran, Thao Truong Dinh ^a   Vo, Toi Van ^a   Lee, Beom Jin ^b  

^a INTERNATIONAL UNIVERSITY   (Viet Nam)

^b Ajou University   (South Korea)

Author keywords

Biomedical application; Magnetic nanoparticles; Surface functionalization; Theranostic

Indexed keywords

CARBON; CHITOSAN; CLONE225; DOXORUBICIN; FERRIC OXIDE; GOLD; IRON OXIDE; MACROGOL; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYACRYLIC ACID; POLYVINYL ALCOHOL; QUANTUM DOT; SC 7269; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ADSORPTION; AUTOCLAVE; BIOCOMPATIBILITY; BIOMEDICAL ENGINEERING; CELL DEATH; CELL SELECTION; CHEMICAL COMPOSITION; CONTRAST ENHANCEMENT; DECOMPOSITION; DELETION MUTANT; DIAGNOSTIC IMAGING; DISPERSION; DRUG DELIVERY SYSTEM; EMULSION; GLIOBLASTOMA; HEAT TREATMENT; HIGH TEMPERATURE; HUMAN; HYDROLYSIS; HYDROPHILICITY; HYDROPHOBICITY; INTERNALIZATION; IONIC STRENGTH; LIVER CANCER; LOW TEMPERATURE; MAGNETIC FIELD; MAGNETIC FLUID HYPERTHERMIA; MAGNETIC SEPARATION; MICROEMULSION; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; PROSTATE CANCER; REVIEW; ROOM TEMPERATURE; SURFACE CHARGE; SURFACE PROPERTY; SYNTHESIS; TENSILE STRENGTH; TISSUE REPAIR; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANIMALS; BIOMEDICAL ENGINEERING; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; MAGNETIC PHENOMENA; NANOPARTICLES;

EID: 84875746811     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1203-7     Document Type: Review

References (105)

1. Babes, L.; Denizot, B.; Amp, X.; Tanguy, G.; Le Jeune, J. J.; and Jallet, P.; Synthesis of iron oxide nanoparticles used as MRI contrast agents: A parametric study. J. Colloid Interface Sci.; 212, 474-482 (1999). (Pubitemid 29394676)
2. Baker, A. S. J.; Brown, A. S. C.; Edwards, M. A.; Hargreaves, J. S. J.; Kiely, C. J.; Meagher, A.; and Pankhurst, Q. A.; A structural study of haematite samples prepared from sulfated goethite precursors: the generation of axial mesoporous voids. J. Mater. Chem.; 10, 761-766 (2000).
3. Bhattarai, S. R.; Bahadur K.C, R.; Aryal, S.; Khil, M. S.; and Kim, H. Y.; N-Acylated chitosan stabilized iron oxide nanoparticles as a novel nano-matrix and ceramic modification. Carbohydr. Polym.; 69, 467-477 (2007). (Pubitemid 46693984)
4. Bhattarai, S. R.; Kc, R. B.; Kim, S. Y.; Sharma, M.; Khil, M. S.; Hwang, P. H.; Chung, G. H.; and Kim, H. Y.; N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. J. Nanobiotechnology, 6, 1 (2008). (Pubitemid 351359624)
5. Binder, W. H. and Weinstabl, H. C.; Surface-modified superparamagnetic iron-oxide nanoparticles. Chem. Mat. Sci.; 138, 315-320 (2007).
6. Butter, K.; Kassapidou, K.; Vroege, G. J.; and Philipse, A. P.; Preparation and properties of colloidal iron dispersions. J. Colloid Interface Sci.; 287, 485-95 (2005). (Pubitemid 40755484)
7. Carmen Bautista, M.; Bomati-Miguel, O.; Del Puerto Morales, M.; Serna, C. J.; and Veintemillas-Verdaguer, S.; Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation. J. Magn. Magn. Mater.; 293, 20-27 (2005). (Pubitemid 40608906)
8. Chastellain, M.; Petri, A.; and Hofmann, H.; Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J. Colloid Interface Sci.; 278, 353-360 (2004). (Pubitemid 39144384)
9. Chen, C.; Jiang, X.; Kaneti, Y. V.; and Yu, A.; Design and construction of polymerized-glucose coated Fe3O4 magnetic nanoparticles for delivery of aspirin. Powder Technol.; DOI10.1016/j.powtec.2012.03.008 (2012).
10. Chen, J.; Wu, H.; Han, D.; and Xie, C.; Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer. Cancer Lett.; 231, 169-175 (2006). (Pubitemid 43038727)
11. Cherukuri, P.; Glazer, E. S.; and Curley, S. A.; Targeted hyperthermia using metal nanoparticles. Adv. Drug Deliv. Rev.; 62, 339-345 (2010).
12. Chomoucka, J.; Drbohlavova, J.; Huska, D.; Adam, V.; Kizek, R.; and Hubalek, J.; Magnetic nanoparticles and targeted drug delivering. Pharmacol. Res.; 62, 144-149 (2010).
13. Colombo, M.; Corsi, F.; Foschi, D.; Mazzantini, E.; Mazzucchelli, S.; Morasso, C.; Occhipinti, E.; Polito, L.; Prosperi, D.; Ronchi, S.; and Verderio, P.; HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches. Pharmacol. Res.; 62, 150-165 (2010).
14. Cornell, R. M. and Schwertmann, U.; The Iron Oxides Structure, Properties, Reactions, Occurrence and Uses, VCH Verlagsgesellschaft Weinheim (1996).
15. Corr, S. A.; Byrne, S. J.; Tekoriute, R.; Meledandri, C. J.; Brougham, D. F.; Lynch, M.; Kerskens, C.; O'dwyer, L.; and Gun'ko, Y. K.; Linear assemblies of magnetic nanoparticles as MRI contrast agents. J. Am. Chem. Soc.; 130, 4214-4215 (2008). (Pubitemid 351466400)
16. David, R.; Groebner, M.; and Franz, W.-M.; Magnetic cell sorting purification of differentiated embryonic stem cells stably expressing truncated human CD4 as surface marker. Stem Cells, 23, 477-482 (2005).
17. De Dios, A. S. and Diaz-Garcia, M. E.; Multifunctional nanoparticles: analytical prospects. Anal. Chim. Acta, 666, 1-22 (2010).
18. De Ha̧n, C.; Conception of the first magnetic resonance imaging contrast agents: a brief history. Top. Magn. Reson. Imaging, 12, 221-230 (2001). (Pubitemid 33031395)
19. De, M.; Ghosh, P. S.; and Rotello, V. M.; Applications of nanoparticles in biology. Adv. Mater.; 20, 4225-4241 (2008).
20. Dilnawaz, F.; Singh, A.; Mohanty, C.; and Sahoo, S. K.; Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. Biomaterials, 31, 3694-3706 (2010).
21. Domingo, C.; RodríGuez-Clemente, R.; and Blesa, M.; Morphological properties of α-FeOOH, γ-FeOOH and Fe3O4 obtained by oxidation of aqueous Fe(II) solutions. J. Colloid Interface Sci.; 165, 244-252 (1994).
22. Frank, J. A.; Zywicke, H.; Jordan, E. K.; Mitchell, J.; Lewis, B. K.; Miller, B.; Bryant, L. H.; Jr.; and Bulte, J. W.; Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol.; 9Suppl 2, S484-S487 (2002). (Pubitemid 34857762)
23. Gao, J.; Gu, H.; and Xu, B.; Multifunctional magnetic nanoparticles: design, synthesis, and biomedical applications. Acc. Chem. Res.; 42, 1097-1107 (2009).
24. Ge, S.; Shi, X.; Sun, K.; Li, C.; Baker, J. R.; Banaszak Holl, M. M.; and Orr, B. G.; A facile hydrothermal synthesis of iron oxide nanoparticles with tunable magnetic properties. J. Phys. Chem. C Nanomater. Interfaces.; 113, 13593-13599 (2009).
25. Gupta, A. K. and Gupta, M.; Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26, 3995-4021 (2005). (Pubitemid 40044762)
26. Gupta, A. K. and Wells, S.; Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans. Nanobioscience, 3, 66-73 (2004).
27. Gupta, R. and Chaudhury, N.; Entrapment of biomolecules in solgel matrix for applications in biosensors: problems and future prospects. Biosens. Bioelectron.; 22, 2387-2399 (2007). (Pubitemid 46484275)
28. Haddad, P. S.; Martins, T. M.; D'souza-Li, L.; Li, L. M.; Metze, K.; Adam, R. L.; Knobel, M.; and Zanchet, D.; Structural and morphological investigation of magnetic nanoparticles based on iron oxides for biomedical applications. Mater. Sci. Eng. C, 28, 489-494 (2008). (Pubitemid 351417797)
29. Hadjipanayis, C. G.; Machaidze, R.; Kaluzova, M.; Wang, L.; Schuette, A. J.; Chen, H.; Wu, X.; and Mao, H.; EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res.; 70, 6303-6312 (2010).
30. Hamoudeh, M.; Al Faraj, A.; Canet-Soulas, E.; Bessueille, F.; Leonard, D.; and Fessi, H.; Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation. Int. J. Pharm.; 338, 248-257 (2007). (Pubitemid 46783978)
31. Herrera, A. P.; Barrera, C.; Zayas, Y.; and Rinaldi, C.; Monitoring colloidal stability of polymer-coated magnetic nanoparticles using AC susceptibility measurements. J. Colloid Interface Sci.; 342, 540-549 (2010).
32. Hohnholt, M. C.; Geppert, M.; and Dringen, R.; Treatment with iron oxide nanoparticles induces ferritin synthesis but not oxidative stress in oligodendroglial cells. Acta Biomater.; 7, 3946-3954 (2011).
33. Hyeon, T.; Chemical synthesis of magnetic nanoparticles. Chem. Commun. (Camb.), 927-934 (2003). (Pubitemid 36469636)
34. Hyeon, T.; Lee, S. S.; Park, J.; Chung, Y.; and Na, H. B.; Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. J. Am. Chem. Soc.; 123, 12798-12801 (2001). (Pubitemid 34015142)
35. Ito, A.; Shinkai, M.; Honda, H.; and Kobayashi, T.; Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng.; 100, 1-11 (2005). (Pubitemid 41573511)
36. Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D. L.; and Labhasetwar, V.; Iron oxide oanoparticles for sustained delivery of anticancer agents. Mol. Pharm.; 2, 194-205 (2005). (Pubitemid 40917416)
37. Jain, T. K.; Richey, J.; Strand, M.; Leslie-Pelecky, D. L.; Flask, C. A.; and Labhasetwar, V.; Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials, 29, 4012-4021 (2008).
38. Jarzyna, P. A.; Skajaa, T.; Gianella, A.; Cormode, D. P.; Samber, D. D.; Dickson, S. D.; Chen, W.; Griffioen, A. W.; Fayad, Z. A.; and Mulder, W. J.; Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials, 30, 6947-6954 (2009).
39. Johannsen, M.; Gneveckow, U.; Thiesen, B.; Taymoorian, K.; Cho, C. H.; Waldöfner, N.; Scholz, R.; Jordan, A.; Loening, S. A.; and Wust, P.; Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-Dimensional temperature distribution. Eur. Urol.; 52, 1653-1662 (2007). (Pubitemid 350052385)
40. Jolivet, J. P.; Belleville, P.; Tronc, E.; and Livage, J.; Influence of Fe(II) on the formation of the spinel iron oxide in alkaline medium. Clays Clay Miner.; 40, 531-539 (1992). (Pubitemid 23390812)
41. Ke, J. H.; Lin, J. J.; Carey, J. R.; Chen, J. S.; Chen, C. Y.; and Wang, L. F.; A specific tumor-targeting magnetofluorescent nanoprobe for dual-modality molecular imaging. Biomaterials, 31, 1707-1715 (2010).
42. Khan, A.; Preparation and characterization of magnetic nanoparticles embedded in microgels. Mater. Lett.; 62, 898-902 (2008). (Pubitemid 350299532)
43. Kim, D. H.; Kim, K. N.; Kim, K. M.; and Lee, Y. K.; Targeting to carcinoma cells with chitosan- and starch-coated magnetic nanoparticles for magnetic hyperthermia. J. Biomed. Mater. Res.; A, 88, 1-11 (2009).
44. Kim, E. H.; Lee, H. S.; Kwak, B. K.; and Kim, B. K.; Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J. Magn. Magn. Mater.; 289, 328-330 (2005). (Pubitemid 40339776)
45. Kirsch, J. E.; Basic principles of magnetic resonance contrast agents. Top. Magn. Reson. Imaging, 3, 1-18 (1991).
46. Kumagai, M.; Imai, Y.; Nakamura, T.; Yamasaki, Y.; Sekino, M.; Ueno, S.; Hanaoka, K.; Kikuchi, K.; Nagano, T.; Kaneko, E.; Shimokado, K.; and Kataoka, K.; Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf. B Biointerfaces, 56, 174-181 (2007). (Pubitemid 46467334)
47. Kumagai, M.; Kano, M. R.; Morishita, Y.; Ota, M.; Imai, Y.; Nishiyama, N.; Sekino, M.; Ueno, S.; Miyazono, K.; and Kataoka, K.; Enhanced magnetic resonance imaging of experimental pancreatic tumor in vivo by block copolymercoated magnetite nanoparticles with TGF-beta inhibitor. J. Control. Release, 140, 306-311 (2009).
48. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; and Muller, R. N.; Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochem ical characterizations, and biological applications. Chem. Rev.; 108, 2064-2110 (2008).
49. Lee, J.; Isobe, T.; and Senna, M.; Preparation of ultrafine Fe3O4 particles by precipitation in the presence of PVA at high pH. J. Colloid Interface Sci.; 177, 490-494 (1996). (Pubitemid 26166485)
50. Li, F.; Sun, J.; Zhu, H.; Wen, X.; Lin, C.; and Shi, D.; Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin. Colloids Surf. B Biointerfaces, 88, 58-62 (2011).
51. Liao, M. -H. and Chen, D.-H.; Preparation and characterization of a novel magnetic nano-adsorbent. J. Mater. Chem.; 12, 3654-3659 (2002).
52. Liu, C.; Wu, X.; Klemmer, T.; Shukla, N.; Weller, D.; Reduction of sintering during annealing of FePt nanoparticles coated with iron oxide. Chem. Mater.; 17, 620-625 (2005). (Pubitemid 40204179)
53. Lu, A. H.; Salabas, E. L.; and Schuth, F.; Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. Engl.; 46, 1222-1244 (2007). (Pubitemid 46981367)
54. Lu, Y.; Yin, Y.; Mayers, B. T.; and Xia, Y.; Modifying the surface properties of superparamagnetic iron oxide nanoparticles through A solgel approach. Nano Lett.; 2, 183-186 (2002). (Pubitemid 135706288)
55. Lübbe, A. S.; Bergemann, C.; Huhnt, W.; Fricke, T.; Riess, H.; Brock, J. W.; and Huhn, D.; Preclinical experiences with magnetic drug targeting: Tolerance and efficacy. Cancer Res.; 56, 4694-4701 (1996). (Pubitemid 26338072)
56. Maeng, J. H.; Lee, D. H.; Jung, K. H.; Bae, Y. H.; Park, I. S.; Jeong, S.; Jeon, Y. S.; Shim, C. K.; Kim, W.; Kim, J.; Lee, J.; Lee, Y. M.; Kim, J. H.; Kim, W. H.; and Hong, S. S.; Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials, 31, 4995-5006 (2010).
57. Maier-Hauff, K.; Ulrich, F.; Nestler, D.; Niehoff, H.; Wust, P.; Thiesen, B.; Orawa, H.; Budach, V.; and Jordan, A.; Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol.; 103, 317-324 (2011).
58. Maury, P. A.; Reinhoudt, D. N.; and Huskens, J.; Assembly of nanoparticles on patterned surfaces by noncovalent interaction. Curr. Opin. Colloid Interface Sci.; 13, 74-80 (2007).
59. Melo, T. F. O.; Da Silva, S. W.; Soler, M. a. G.; Lima, E. C. D.; and Morais, P. C.; Investigation of surface passivation process on magnetic nanoparticles by Raman spectroscopy. Surf. Sci.; 600, 3642-3645 (2006). (Pubitemid 44436353)
60. Meng, J.; Fan, J.; Galiana, G.; Branca, R. T.; Clasen, P. L.; Ma, S.; Zhou, J.; Leuschner, C.; Kumar, C. S. S. R.; Hormes, J.; Otiti, T.; Beye, A. C.; Harmer, M. P.; Kiely, C. J.; Warren, W.; Haataja, M. P.; and Soboyejo, W. O.; LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI. Mater. Sci. Eng. C, 29, 1467-1479 (2009).
61. Mikhaylova, M.; Kim, D. K.; Bobrysheva, N.; Osmolowsky, M.; Semenov, V.; Tsakalakos, T.; and Muhammed, M.; Superparamagnetism of magnetite nanoparticles: dependence on surface modification. Langmuir, 20, 2472-2477 (2004).
62. Minges Wols, H. A.; and Witte, P. L.; Plasma cell purification from murine bone marrow using a two-step isolation approach. J. Immunol. Methods, 329, 219-224 (2008). (Pubitemid 350245502)
63. Mohapatra, M. and Anand, S.; Synthesis and applications of nano-structured iron oxides/hydroxides - a review. Int. J. Eng. Sci. Technol.; 2, 127-146 (2010).
64. Morais, P. C.; Santos, R. L.; Pimenta, A. C. M.; Azevedo, R. B.; and Lima, E. C. D.; Preparation and characterization of ultra-stable biocompatible magnetic fluids using citratecoated cobalt ferrite nanoparticles. Thin Solid Films, 515, 266-270 (2006). (Pubitemid 44572092)
65. Mornet, S.; Portier, J.; and Duguet, E.; A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran. J. Magn. Magn. Mater.; 293, 127-134 (2005). (Pubitemid 40608920)
66. Munnier, E.; Cohen-Jonathan, S.; Linassier, C.; Douziech-Eyrolles, L.; Marchais, H.; Souce, M.; Herve, K.; Dubois, P.; and Chourpa, I.; Novel method of doxorubicin-SPION reversible association for magnetic drug targeting. Int. J. Pharm.; 363, 170-176 (2008).
67. Omer, M.; Haider, S.; and Park, S.-Y.; A novel route for the preparation of thermally sensitive core-shell magnetic nanoparticles. Polymer, 52, 91-97 (2011).
68. Pantic, I.; Magnetic nanoparticles in cancer diagnosis and treatment: novel approaches. Rev. Adv. Mater. Sci.; 26, 67-73 (2010).
69. Park, J.; An, K.; Hwang, Y.; Park, J. G.; Noh, H. J.; Kim, J. Y.; Park, J. H.; Hwang, N. M.; and Hyeon, T.; Ultra-largescale syntheses of monodisperse nanocrystals. Nat. Mater.; 3, 891-895 (2004).
70. Parveen, S.; Misra, R.; and Sahoo, S. K.; Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine, 8, 147-166 (2012).
71. Pascal, C.; Pascal, J. L.; Favier, F.; Elidrissi Moubtassim, M. L.; and Payen, C.; Electrochemical synthesis for the control of γ-Fe2O3 nanoparticle size. Morphology, microstructure, and magnetic behavior. Chem. Mater.; 11, 141-147 (1998).
72. Paul, B. K. and Moulik, S. P.; Uses and applications of microemulsions. Curr. Sci.; 80, 990-1001 (2001). (Pubitemid 33620215)
73. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; and Langer, R.; Nanocarriers as an emerging platform for cancer therapy. Nat. Nano, 2, 751-760 (2007). (Pubitemid 350223348)
74. Piao, Y.; Kim, J.; Na, H. B.; Kim, D.; Baek, J. S.; Ko, M. K.; Lee, J. H.; Shokouhimehr, M.; and Hyeon, T.; Wrap-bakepeel process for nanostructural transformation from beta-FeOOH nanorods to biocompatible iron oxide nanocapsules. Nat. Mater.; 7, 242-247 (2008). (Pubitemid 351313823)
75. Prabha, S.; Zhou, W. Z.; Panyam, J.; and Labhasetwar, V.; Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm.; 244, 105-115 (2002). (Pubitemid 35245451)
76. Qiao, T.; Wu, Y.; Jin, J.; Gao, W.; Xie, Q.; Wang, S.; Zhang, Y.; and Deng, H.; Conjugation of catecholamines on magnetic nanoparticles coated with sulfonated chitosan. Colloids Surf. A Physicochem. Eng. Asp.; 380, 169-174 (2011).
77. Rahimi, M.; Wadajkar, A.; Subramanian, K.; Yousef, M.; Cui, W.; Hsieh, J. T.; and Nguyen, K. T.; In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine, 6, 672-680 (2010).
78. Rühle, M. and Ernst, F.; High-resolution imaging and spectrometry of materials, Springer (2003).
79. Santra, S.; Tapec, R.; Theodoropoulou, N.; Dobson, J.; Hebard, A.; and Tan, W.; Synthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: The effect of nonionic surfactants. Langmuir, 17, 2900-2906 (2001). (Pubitemid 35330470)
80. Sanvicens, N. and Marco, M. P.; Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol.; 26, 425-433 (2008).
81. Schweiger, C.; Pietzonka, C.; Heverhagen, J.; and Kissel, T.; Novel magnetic iron oxide nanoparticles coated with poly (ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging. Int. J. Pharm.; 408, 130-137 (2011).
82. Small, A. C. and Johnston, J. H.; Novel hybrid materials of magnetic nanoparticles and cellulose fibers. J. Colloid Interface Sci.; 331, 122-126 (2009).
83. Stöber, W.; Fink, A.; and Bohn, E.; Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci.; 26, 62-69 (1968).
84. 3 particles from condensed ferric hydroxide gel. J. Colloid Interface Sci.; 152, 587-590 (1992).
85. Sun, C.; Lee, J. S.; and Zhang, M.; Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv. Rev, 60, 1252-1265 (2008).
86. Sun, S.; Murray, C. B.; Weller, D.; Folks, L.; and Moser, A.; Monodisperse FePt nanoparticles and ferromagnetic FePt nanocrystal superlattices. Science, 287, 1989-1992 (2000). (Pubitemid 30158668)
87. Sun, S. and Zeng, H.; Size-controlled synthesis of magnetite nanoparticles. J. Am. Chem. Soc.; 124, 8204-8205 (2002). (Pubitemid 34875378)
88. 4 (M = Fe, Co, Mn) nanoparticles. J. Am. Chem. Soc.; 126, 273-279 (2003). (Pubitemid 38090367)
89. Tartaj, P.; Morales, M. P.; Veintemillas-Verdaguer, S.; Gonzalez-Carreno, T.; and Serna, C. J.; Synthesis, properties and biomedical applications of magnetic nanoparticles, Amsterdam, The Netherlands, Elsevier (2006).
90. Thoeny, H. C.; Triantafyllou, M.; Birkhaeuser, F. D.; Froehlich, J. M.; Tshering, D. W.; Binser, T.; Fleischmann, A.; Vermathen, P.; and Studer, U. E.; Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur. Urol.; 55, 761-769 (2009).
91. Vogt, C.; Toprak, M.; Muhammed, M.; Laurent, S.; Bridot, J.-L.; and Müller, R.; High quality and tuneable silica shell-magnetic core nanoparticles. J. Nano. Res.; 12, 1137-1147 (2010).
92. Vonarbourg, A.; Passirani, C.; Saulnier, P.; and Benoit, J. P.; Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials, 27, 4356-4373 (2006). (Pubitemid 43674179)
93. 4 nanoparticles with improved magnetic properties. Mater. Res. Bull.; 38, 1113-1118 (2003).
94. Wang, S.; Jarrett, B. R.; Kauzlarich, S. M.; and Louie, A. Y.; Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. J. Am. Chem. Soc.; 129, 3848-3856 (2007). (Pubitemid 46595506)
95. Weissleder, R.; Kelly, K.; Sun, E. Y.; Shtatland, T.; and Josephson, L.; Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotechnol.; 23, 1418-1423 (2005). (Pubitemid 41679395)
96. Willard, M. A.; Kurihara, L. K. C.; E. E.; Calvin, S.; and Harris, V. G.; Encyclopedia of Nanoscience and Nanotechnology, CA, Valencia (2004).
97. Willis, A. L.; Turro, N. J.; and O'brien, S.; Spectroscopic characterization of the surface of iron oxide nanocrystals, Washington, DC, ETATS-UNIS, American Chemical Society (2005).
98. Xu, Z. Z.; Wang, C. C.; Yang, W. L.; Deng, Y. H.; and Fu, S. K.; Encapsulation of nanosized magnetic iron oxide by polyacrylamide via inverse miniemulsion polymerization. J. Magn. Magn. Mater.; 277, 136-143 (2004).
99. Yan, X.; Scherphof, G. L.; and Kamps, J. A.; Liposome opsonization. J. Liposome Res.; 15, 109-139 (2005). (Pubitemid 40976309)
100. Yokoyama, T.; Tam, J.; Kuroda, S.; Scott, A. W.; Aaron, J.; Larson, T.; Shanker, M.; Correa, A. M.; Kondo, S.; Roth, J. A.; Sokolov, K.; and Ramesh, R.; EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLoS One, 6, e25507 (2011).
101. Yuan, C. and Kerwin, W. S.; MRI of atherosclerosis. J. Magn. Reson. Imaging, 19, 710-719 (2004). (Pubitemid 38788654)
102. 4 @poly(2-hydroxyethyl methacrylate)-graft-poly(ε-caprolactone) magnetic nanoparticles with branched brush polymeric shell. Polymer, 51, 2540-2547 (2010).
103. 4-chitosan nanoparticles under UV irradiation in aqueous system. Curr. Appl. Phys.; 10, 828-833 (2010).
104. Zhang, Y.; Wang, H.; Yan, B.; Zhang, Y.; Li, J.; Shen, G.; and Yu, R.; A reusable piezoelectric immunosensor using antibody-adsorbed magnetic nanocomposite. J. Immunol. Methods, 332, 103-111 (2008).
105. 4 magnetic nanoparticles used as targeted-drug carriers. Chinese J. Chem. Eng.; 16, 451-455 (2008).